| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Friday, October 14, 2022 10:35:13 AM
Saw an interview with the FL surggen where he basically said, "we dont recommend medicine that kills people", referencing the 84% increase in ""events"" with the referenced group.
As i previously stated, there was already a great divide in society but the polarization has only gotten worse since covid emerged.
One side generally adopts a "you do you and i'll do me" mindset, while the other is all in with the "its my view and my way or else".......what absolute bollocks!
Lets hope that the cdc/fda gets their collective heads out their arses and start doing whats most beneficial for public health instead of being the marketing arm of BP.
Skeptical they will but still hopeful.
As i previously stated, there was already a great divide in society but the polarization has only gotten worse since covid emerged.
One side generally adopts a "you do you and i'll do me" mindset, while the other is all in with the "its my view and my way or else".......what absolute bollocks!
Lets hope that the cdc/fda gets their collective heads out their arses and start doing whats most beneficial for public health instead of being the marketing arm of BP.
Skeptical they will but still hopeful.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
